What is orexin, and why does it matter for wakefulness? Orexin, also called hypocretin, is a chemical messenger made by a small group of cells in the hypothalamus. It helps the brain maintain a stable waking state. When this signalling system is severely disrupted, sleep and wakefulness can intrude into one another, as happens in narcolepsy type 1.
The discovery has received fresh attention because Emmanuel Mignot and Masashi Yanagisawa were awarded the 2026 Albert Lasker Basic Medical Research Award for revealing orexin’s role in wakefulness and narcolepsy. Their work changed the scientific picture of sleep. Rather than treating sleep as a simple switch, it showed that the brain also needs systems that stabilise wakefulness.
Evidence checked: 14 September 2026. This explainer is based on the official 2026 Lasker Award account, landmark peer-reviewed studies cited by the Foundation and current NHS guidance on narcolepsy and excessive daytime sleepiness.
Orexin and wakefulness at a glance
- Two names, one system: orexin and hypocretin refer to the same pair of related signalling molecules.
- Where it begins: orexin is produced by a relatively small population of cells in the hypothalamus, a brain region involved in sleep, wakefulness and other body functions.
- What it does: orexin helps sustain and stabilise wakefulness by signalling to several arousal networks across the brain.
- Why narcolepsy matters: many people with narcolepsy type 1 have lost most of the cells that make orexin, or have very low levels of it.
- What it does not mean: feeling tired after too little sleep does not by itself show that someone has low orexin or narcolepsy.
- When to seek help: persistent excessive daytime sleepiness, sudden sleep attacks or episodes of emotion-triggered muscle weakness should be discussed with a GP.
How was orexin discovered?
The story came together from two very different lines of research in the late 1990s. Yanagisawa’s team was studying previously unexplained receptors on cells. It identified two small peptides that activated a pair of those receptors and named them orexins. At first, their location in the hypothalamus and their effect on feeding made appetite seem like the main story.
Then genetically modified mice without orexin began to show sudden collapses and unusual transitions into rapid eye movement, or REM, sleep. Around the same time, Mignot’s team completed a long search for the genetic cause of inherited narcolepsy in dogs. The answer was a mutation affecting one of the orexin receptors.
Human evidence completed the picture. Many people with the form of narcolepsy that includes cataplexy had very low or undetectable orexin in their cerebrospinal fluid, and post-mortem studies found a major loss of orexin-producing cells. The converging results linked one signalling pathway across mice, dogs and humans.
The Lasker Foundation recognised Mignot and Yanagisawa in 2026 for identifying orexin’s role in maintaining wakefulness and showing how its deficiency is involved in narcolepsy. This award celebrates foundational research conducted over many years. It is not a new test that people can perform at home and it does not turn every experience of tiredness into a neurological disorder.
Does orexin switch sleep on and off?
Not on its own. Sleep and wakefulness are produced by interacting systems, including circadian timing, sleep pressure and networks that promote either arousal or sleep. Orexin is best understood as an important stabiliser within that wider system.
During a normal day, wake-promoting networks help the brain stay alert and responsive. At night, rising sleep pressure and the timing signal from the body clock favour sleep. Orexin connects with several arousal systems and helps prevent abrupt, poorly timed transitions between states.
This explains why a severe loss of orexin signalling can affect more than total hours asleep. Someone with narcolepsy may have fragmented night sleep as well as excessive daytime sleepiness. Features normally associated with REM sleep can also appear around waking, such as sleep paralysis, vivid dream-like experiences or cataplexy.
For more on the other parts of this system, read our guides to circadian rhythm, sleep pressure and sleep cycles.
Ordinary tiredness and excessive daytime sleepiness are not the same
Most people feel sleepy after a short night, an unusually long day, illness, stress, alcohol or a disrupted routine. That is a common response to circumstances. It often improves when the cause is addressed and enough time is allowed for sleep.
Excessive daytime sleepiness is different from simply feeling low in energy. It means repeatedly struggling to stay awake or falling asleep during the day. Narcolepsy is one possible cause, but it is not the only one. The NHS also points to sleep apnoea, restless legs, some medicines, depression, alcohol or drug use and other physical or mental health conditions.
That is why symptoms need proper assessment rather than self-diagnosis. A GP may review sleep habits, medicines and other health factors, and can refer someone to a sleep specialist when necessary. Specialist assessment can include an overnight sleep study and a daytime test of how quickly someone falls asleep.
What are the main signs of narcolepsy?
The NHS describes narcolepsy as a rare, long-term brain condition that disrupts the regulation of sleeping and waking. Symptoms vary, and not everyone experiences all of them.
- Excessive daytime sleepiness: persistent drowsiness and difficulty concentrating or staying awake.
- Sleep attacks: falling asleep suddenly, sometimes without warning.
- Cataplexy: a brief loss of muscle control, often triggered by emotions such as laughter, excitement, anger or surprise.
- Sleep paralysis: a temporary inability to move or speak while falling asleep or waking.
- Dream-like experiences: vivid images or sounds around the boundary between sleep and wakefulness.
- Disturbed night sleep: frequent waking or unusually fragmented sleep.
Sleep paralysis or a vivid dream on its own is common and does not prove narcolepsy. The pattern, frequency and effect on daily life matter. Speak to a GP if sleepiness is persistent, affects work, education or safety, or comes with sleep attacks or cataplexy. Do not drive if you feel sleepy.
Can lifestyle choices raise orexin?
There is no validated home method for measuring orexin, and everyday lifestyle advice should not be presented as a way to repair orexin deficiency. Food, exercise, light and sleep timing can influence alertness through many pathways, but that does not mean a particular routine, supplement or product treats narcolepsy.
For most people, the practical priority is simpler: allow enough time for sleep, keep timing reasonably consistent and reduce avoidable disruption. If daytime sleepiness remains severe despite adequate opportunity for sleep, seek clinical advice rather than trying to optimise a single brain chemical.
What does this mean for the sleep environment?
A mattress cannot increase orexin, diagnose narcolepsy or treat excessive daytime sleepiness. Those are medical matters. The sleep environment still has a different, valid role: it can reduce physical barriers that disturb the sleep opportunity someone has.
- Protect enough time: even a comfortable bed cannot compensate for a consistently shortened sleep opportunity.
- Reduce discomfort: appropriate support and pressure relief may help limit avoidable tossing, turning or waking caused by physical discomfort.
- Manage heat: breathable bedding and a comfortably cool room can reduce temperature-related disruption.
- Control light and noise: a dark, quiet environment supports the timing and continuity of sleep without claiming to change orexin biology.
- Notice the pattern: if someone is repeatedly falling asleep unexpectedly or cannot stay awake despite enough sleep opportunity, comfort changes are not an adequate response. Clinical assessment matters.
Our Sleep Health Hub explains how sleep timing, pressure, temperature, comfort and support work together. Each factor has a place, but none should be oversold as a treatment for a neurological sleep disorder.
Frequently asked questions about orexin and wakefulness
Is orexin the same as hypocretin?
Yes. Two research groups discovered the same signalling molecules independently and gave them different names. Both terms remain in use. Clinical information may refer to either orexin or hypocretin.
Does orexin make you feel awake?
Orexin helps sustain and stabilise wakefulness by activating several arousal systems in the brain. It is important, but it works alongside the body clock, sleep pressure and other chemical messengers rather than acting as a single on-off switch.
Does low orexin always mean narcolepsy?
Severely low orexin is strongly associated with narcolepsy type 1, especially when cataplexy is present, but narcolepsy is diagnosed by specialists using the full clinical picture and appropriate tests. Not every form of narcolepsy involves confirmed orexin deficiency.
Is daytime tiredness a sign of narcolepsy?
It can be one sign, but daytime sleepiness has many possible causes. A short sleep opportunity, sleep apnoea, medicines, mood problems and other conditions can all contribute. Persistent or severe sleepiness needs assessment rather than a self-diagnosis.
Can a supplement increase orexin?
No over-the-counter supplement is established as a treatment for orexin deficiency or narcolepsy. Avoid products that promise to fix a brain signalling system without clinical evidence. Speak to a GP or sleep specialist about symptoms and treatment.
Can a better mattress treat excessive daytime sleepiness?
No. A suitable mattress may reduce discomfort, poor support or excess heat that interrupts sleep, but it cannot treat narcolepsy, restore orexin or resolve every cause of excessive daytime sleepiness.
References
- Lasker Foundation. Orexin, a brain peptide that maintains wakefulness. 2026 Albert Lasker Basic Medical Research Award. Read the official award account.
- Lin L et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98:365-376. DOI: 10.1016/S0092-8674(00)81965-0. View the journal record.
- Chemelli RM et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437-451. DOI: 10.1016/S0092-8674(00)81973-X. View the journal record.
- Peyron C et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine. 2000;6:991-997. DOI: 10.1038/79690. View the journal record.
- NHS. Narcolepsy. Read NHS guidance.
- NHS. Excessive daytime sleepiness (hypersomnia). Read NHS guidance.
This article is for general information only and is not a substitute for medical advice, diagnosis or treatment. If you have persistent excessive daytime sleepiness, sudden sleep attacks, cataplexy or concerns about driving safety, speak to a GP and follow current NHS and DVLA guidance.